Successful management of trichotillomania in a patient with SSRI-induced hypersomnia: a case report - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Effective Treatment of Trichotillomania in a Patient Experiencing Hypersomnia Due to SSRI: A Case Study

  • By

  • Deemah Ateeq Alateeq

  • August 20, 2026

Share

  • 1

    Trichotillomania management often involves serotonergic pharmacotherapy, but options are limited for patients intolerant to first-line medications.

  • 2

    A 25-year-old female with severe trichotillomania experienced debilitating hypersomnia from SSRIs, leading to academic decline.

  • 3

    After failing two SSRIs, the patient was treated with bupropion and mindfulness-based behavioral therapy, resulting in significant improvement.

  • 4

    The patient's improvement was maintained for 24 months after stopping bupropion, while she continued mindfulness practice.

  • 5

    This case highlights the potential of bupropion as a treatment for trichotillomania in patients with SSRI intolerance.

Original Source(s)

Successful management of trichotillomania in a patient with SSRI-induced hypersomnia: a case report

  • by Deemah Ateeq Alateeq

  • August 20, 2026

Related Content

HHS Announces Historic Investment to Expand Health Center Program, Bringing Primary Care to Nearly 1 Million More Americans

Catch My Drift: Building Scalable and Sustainable Models for Promoting Clinician Adherence to Evidence-Based Treatments for Eating Disorders

Firearm Injuries and Deaths Might Be Preventable With Better Local Data